[Platelet alloimmunization in patients with oncologic blood disorders treated with multiple transfusions: prospective study in adults and children].

@article{Pereira1997PlateletAI,
  title={[Platelet alloimmunization in patients with oncologic blood disorders treated with multiple transfusions: prospective study in adults and children].},
  author={Jaime A Pereira and Luc{\'i}a Bronfman and Pablo Bert{\'i}n and E Marzouka and Patricia Hidalgo and Shinjiro Amaya and Diego Mezzano},
  journal={Revista medica de Chile},
  year={1997},
  volume={125 11},
  pages={1305-12}
}
BACKGROUND Refractoriness continues to be a major complication of platelet transfusion therapy in patients with multiple transfusions. Despite most cases are secondary to non-immune causes, the most serious is that associated to alloimmunization. The incidence and consequences of HLA and non-HLA (platelet specific) antibodies are unknown in our country… CONTINUE READING